Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Oxurion NV (0G99)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.01 0.00    0.00%
01/01 - Real-time Data. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.01 - 0.01
Type:  Equity
Market:  United Kingdom
ISIN:  BE0003846632 
SEDOL:  B28MVS6
Oxurion 0.01 0.00 0.00%

0G99 Balance Sheet

 
Assess the latest Oxurion NV balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced OXUR Annual Report data, financial summaries and charts are available for Oxurion NV investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 2.74 2.74 7.48 7.48
Cash and Short Term Investments 1.67 1.67 2.23 2.23
Cash - - - -
Cash & Equivalents 1.62 1.62 2.18 2.18
Short Term Investments 0.05 0.05 0.049 0.049
Total Receivables, Net 1.07 1.07 5.25 5.25
Accounts Receivables - Trade, Net 0.878 0.115 4.29 4.29
Total Inventory - - - -
Prepaid Expenses 0.433 0.433 - -
Other Current Assets, Total 0.001 0.001 - -
Total Assets 6.55 6.55 11.82 11.82
Property/Plant/Equipment, Total - Net 0.245 0.245 1.12 1.12
Property/Plant/Equipment, Total - Gross 11.26 11.26 - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments - - - -
Note Receivable - Long Term 0.517 0.517 0.959 0.959
Other Long Term Assets, Total 3.56 3.56 3.21 3.21
Other Assets, Total -0.581 -0.581 -5.2 -5.2
Total Current Liabilities 19.61 - 18.65 18.65
Accounts Payable 4.94 - 6.48 6.48
Payable/Accrued - - - -
Accrued Expenses - 0.702 - -
Notes Payable/Short Term Debt - 12.01 - -
Current Port. of LT Debt/Capital Leases 0.211 12.22 9.32 9.32
Other Current liabilities, Total 2.45 1.75 2.85 2.85
Total Liabilities 19.74 19.74 20.44 20.44
Total Long Term Debt 0.117 0.117 1.63 1.63
Long Term Debt - - 0.766 0.766
Capital Lease Obligations 0.117 0.117 0.864 0.864
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total -11.99 -11.99 0.159 0.159
Total Equity -13.19 -13.19 -8.62 -8.62
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 72.99 72.99 70.29 70.29
Additional Paid-In Capital 0.25 0.25 0.25 0.25
Retained Earnings (Accumulated Deficit) -111.57 -111.57 -84.03 -84.03
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 25.14 25.14 4.86 4.86
Total Liabilities & Shareholders' Equity 6.55 6.55 11.82 11.82
Total Common Shares Outstanding 3489.46 3489.46 531.15 531.15
Total Preferred Shares Outstanding - - - -
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OXUR Price Commentary

Write your thoughts about ThromboGenics NV
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andreas El Diablo
Andreas El Diablo Nov 16, 2022 18:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is this a bull phase? Or will it crash back to earth? My guess is €1.25 by 01/12/22
Peter Erika
Peter Erika Nov 16, 2022 18:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
that never happened did it
Mike Jo
Mike Jo Aug 20, 2019 11:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ceo Patrick de haes needs to resign. Jetrea commercial flop followed by clinical failure after clinical failure.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email